Chaysavanh Manichanh Institutions of which they are part Head of group Microbiome Research Vall Hebron Institut de Recerca Email Chaysavanh Manichanh Email Institutions of which they are part Head of group Microbiome Research Vall Hebron Institut de Recerca
Research lines Gut Microbiota The human microbiome is the collective genomes of all microorganisms living at the multiple sites of the human body (oral cavity, skin, nasal cavity, gastrointestinal tract (GI) and vagina). Human (Homo sapiens) and their commensal microorganisms have evolved together over the last 200,000 years and have become dependent on one another. Interaction between humans and their symbiotic bacteria is essential to many aspects of normal ‘mammalian’ physiology, ranging from metabolic activity to immune homeostasis, and ecological or genetic changes that disturb this mutualism can result in disease. It reflects the evolutionary selection pressures acting at both the levels of the host and the microbial cells and has a direct profound impact on human health. This line of research aims at understanding the role of the gut microbiome in intestinal disorders using ‘omics approaches.Our research group proposes a service-collaboration in Microbiome analysis. You can find further information on our prices at the following URL. IP: Chaysavanh Manichanh The Human Microbiome The Microbiome Research Group seeks to investigate the role of the microbiota in health and disease. Its secondary objectives include:1. Role of the microbiota in health and disease 2. Tools to characterize the microbiome structure and function3. Micro-biomarkers for diagnosis and prognosis4. Fecal microbiota transplantation as a therapeutic strategy5. Impact of diet on the gut microbial ecosystem IP: Chaysavanh Manichanh Projects Modulación de la microbiota intestinal y el sistema inmunológicoModulación de la microbiota intestinal y el sistema inmunológico (MICROBIMM) IP: Chaysavanh Manichanh Collaborators: Modulación de la microbiota intestinal y el sistema inmunológicoModulación de la microbiota intestinal y el sistema inmunológico, Modulación de la microbiota intestinal y el sistema inmunológicoModulación de la microbiota intestinal y el sistema inmunológico, Sara Vega Abellaneda, Luis Fernando Mayorga Ayala Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 237500 Reference: PID2023-147387OB-I00 Duration: 01/09/2024 - 31/08/2028 El déficit de CFTR facilita la carcinogénesis pancreática y potencia el crecimiento, la agresividad tumoral y las metástasis IP: Chaysavanh Manichanh Collaborators: El déficit de CFTR facilita la carcinogénesis pancreática y potencia el crecimiento, la agresividad tumoral y las metástasis, El déficit de CFTR facilita la carcinogénesis pancreática y potencia el crecimiento, la agresividad tumoral y las metástasis Funding agency: Instituto de Salud Carlos III Funding: 95000 Reference: CD22/00177 Duration: 01/03/2023 - 28/02/2025 Fisiologia i fisiopatologia digestiva IP: Chaysavanh Manichanh Collaborators: Itxarone Izaskun Bilbao Aguirre, Fisiologia i fisiopatologia digestiva, Jordi Barquinero Mañez, Oscar Segarra Canton, Gerard Serrano Gomez, Cristina Dopazo Taboada, Rocío Piñera Moreno Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 40000 Reference: 2021 SGR 00459 Duration: 01/01/2022 - 30/06/2025 X IP: Laia Perez Lasarte Collaborators: Gerard Serrano Gomez, Chaysavanh Manichanh , X Funding agency: Fundació Institut de Recerca HUVH Funding: 56357.41 Reference: VHIR/PHDPROGRAMME/2022/SERRANO Duration: 01/07/2022 - 30/09/2025 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page »
